Abstract
Introduction: Our understanding of risk factors for COVID‑19, including pre-existing medical conditions and genetic variations, is limited. To what extent the pre-existing clinical condition and genetic background have implications for COVID-19 still needs to be explored.
Methods: Our study included 389,620 participants of European descent from the UK Biobank, of whom 3,884 received the COVID-19 test and 1,091 were tested positive for COVID-19. We examined the association of COVID-19 status with an extensive list of 974 medical conditions and 30 blood biomarkers. Additionally, we tested the association of genetic variants in two key genes related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2), with COVID-19 or any other phenotypes.
Results: The most significant risk factors for COVID-19 include Alzheimer’s disease (OR = 2.29, 95% CI: 1.25-4.16), dementia (OR = 2.16, 95% CI: 1.36-3.42), and the overall category of delirium, dementia, amnestic and other cognitive disorders (OR = 1.90, 95% CI: 1.24-2.90). Evidence suggesting associations of genetic variants in SARS-CoV-2 infection-related genes with COVID-19 (rs7282236, OR = 1.33, 95% CI: 1.14-1.54, p = 2.31 × 10 -4 ) and other phenotypes, such as an immune deficiency (p = 5.65 × 10 -5 ) and prostate cancer (p = 1.1 × 10 -5 ), was obtained.
Conclusions: Our unbiased and extensive search identified pre-existing Alzheimer’s disease and dementia as top risk factors for hospital admission due to COVID-19, highlighting the importance of providing special protective care for patients with cognitive disorders during this pandemic. We also obtained evidence suggesting a direct association of genetic variants with COVID-19.
Keywords: Alzheimer’s disease; COVID-19; Cognitive disorders; Dementia; Pre-existing conditions; Risk factors.
【저자키워드】 COVID-19, Risk factors, cognitive disorders, Dementia, Alzheimer's disease, Pre-existing conditions, TMPRSS2, 【초록키워드】 SARS-CoV-2, ACE2, coronavirus, pandemic, Biomarkers, Risk factors, UK biobank, Infection, protease, risk factor, severe acute respiratory syndrome Coronavirus, angiotensin-converting enzyme 2, immune, COVID‐19, cognitive disorders, Dementia, delirium, Patient, Factors, Alzheimer's disease, Prostate cancer, Hospital admission, genetic variants, Genetic variant, respiratory, transmembrane protease serine 2, disease, Care, Blood, Protective, association, Angiotensin-converting enzyme, Evidence, angiotensin, Genetic variations, COVID-19 test, direct association, immune deficiency, Phenotypes, deficiency, cognitive, acute respiratory syndrome, Serine, 95% CI, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, enzyme, participant, transmembrane, clinical condition, disorder, positive, genetic background, serine 2, implication, European, amnestic, tested, examined, include, was obtained, highlighting, medical condition, with COVID-19, 【제목키워드】 Hospitalization, cognitive disorders, Observational cohort study, Result, Cognitive disorder,